Objective: To assess treatment satisfaction and decision regret post robot-assisted radical prostatectomy (RARP) and correlate these with clinical, demographic and quality of life indicators. Our study took place at a high-volume United Kingdom center and patients were assessed at a minimum of 18 months postsurgery.
Methods: Patients who underwent RARP between June 2011 and May 2016 were invited to participate through mailed questionnaires.